Literature DB >> 7870195

Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.

K Wedzony1, K Gołembiowska, M Zazula.   

Abstract

In the present study we compared effects of the competitive and non-competitive NMDA antagonists CGP 37849 and MK-801, respectively, on sensorimotor gating in rats, measured as prepulse-induced inhibition of the acoustic startle response, and the outflow of dopamine in the rat prefrontal cortex. CGP 37849 (10, 20 mg/kg), decreased the amplitude of the acoustic startle response, but was without effect on the prepulse-induced inhibition of the acoustic startle response. MK-801 (0.4 but not 0.2 mg/kg) enhanced the amplitude of the acoustic startle response and its doses of 0.2 and 0.4 mg/kg markedly attenuated the prepulse-induced inhibition of the acoustic startle response. The effects of MK-801 (0.4 mg/kg) on the prepulse-induced inhibition of the acoustic startle response were not antagonized by the selective antagonists of D-2 and D-1 dopaminergic receptors, S(-)sulpiride (25 mg/kg) and SCH 23390 (0.1 mg/kg), respectively. When given alone, S(-)sulpiride attenuated the amplitude of the acoustic startle response and failed to altered the prepulse-induced inhibition of the acoustic startle response. SCH 23390 (0.1 mg/kg) failed to alter the amplitude and prepulse-induced inhibition of the acoustic startle response. The effects of CGP 37849 and MK-801 also differed with respect to dopamine outflow. MK-801 (0.2 and 0.4 mg/kg) enhanced the outflow of dopamine in the rat prefrontal cortex, while CGP 37849 (10 and 20 mg/kg) was without any effect on the extracellular concentration of dopamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870195     DOI: 10.1007/bf00173026

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  46 in total

1.  Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine.

Authors:  B Moghaddam; B S Bunney
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

2.  Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine.

Authors:  N R Swerdlow; R S Mansbach; M A Geyer; L Pulvirenti; G F Koob; D L Braff
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.

Authors:  T Klockgether; L Turski
Journal:  Ann Neurol       Date:  1990-10       Impact factor: 10.422

4.  Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.

Authors:  W J Schmidt; M Bubser
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

5.  Glutamate antagonists in the reticular formation reduce the acoustic startle response.

Authors:  W Krase; M Koch; H U Schnitzler
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

6.  Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.

Authors:  J Zhang; L A Chiodo; A S Freeman
Journal:  Brain Res       Date:  1992-09-11       Impact factor: 3.252

7.  NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study.

Authors:  J P Kiss; E Tóth; A Lajtha; E S Vizi
Journal:  Brain Res       Date:  1994-03-28       Impact factor: 3.252

8.  Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

Authors:  R S Mansbach; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1989-12       Impact factor: 7.853

9.  CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.

Authors:  G E Fagg; H R Olpe; M F Pozza; J Baud; M Steinmann; M Schmutz; C Portet; P Baumann; K Thedinga; H Bittiger
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

10.  Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.

Authors:  E D French; J Ferkany; M Abreu; S Levenson
Journal:  Neuropharmacology       Date:  1991-10       Impact factor: 5.250

View more
  7 in total

1.  Adaptive changes in the rat dopaminergic transmission following repeated lithium administration.

Authors:  M Dziedzicka-Wasylewska; M Maćkowiak; K Fijat; K Wedzony
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.

Authors:  K Wedzony; A Czyrak; M Maćkowiak; K Fijał
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

3.  Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs.

Authors:  G B Varty; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

4.  The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.

Authors:  J Maj; Z Rogóz; G Skuza; K Wedzony
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 5.  Advantages and Limitations of Animal Schizophrenia Models.

Authors:  Magdalena Białoń; Agnieszka Wąsik
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

6.  1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.

Authors:  Małgorzata Pietraszek; Jerzy Michaluk; Irena Romańska; Agnieszka Wasik; Krystyna Gołembiowska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-08-01       Impact factor: 3.911

7.  Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

Authors:  B Adams; B Moghaddam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.